300942 易瑞生物
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资64,916-17.33%78,520100,690145,179195,758
投资性房地产0--0000
固定资产569,786-1.08%576,013363,11157,10283,986
在建工程2,2620.00%2,262199,793356,626190,867
无形资产36,865-1.30%37,35139,24341,39342,400
商誉0--0000
其他非流动资产15,87926.14%12,5882,71318,37095,026
689,707-2.41%706,734705,550618,669608,036

流动资产
货币资金412,0154.88%392,838293,399481,749247,451
应收账款101,798-7.63%110,21094,05976,14883,878
存货62,27613.70%54,77440,43031,461100,608
其他流动资产222,166-14.55%259,991323,728148,312242,482
798,255-2.39%817,814751,616737,670674,419

流动负债
短期借款11,000-47.62%21,000000
应付票据0--0000
应付帐款44,768-38.64%72,95558,76277,35265,107
其他流动负债53,690-19.56%66,74893,19559,575134,676
109,458-31.89%160,703151,958136,927199,784
流动资产净值688,7974.82%657,111599,658600,743474,636
资产总额减流动负债1,378,5041.07%1,363,8451,305,2081,219,4121,082,672

非流动负债
长期借款174,51511.89%155,967163,218100,32956,320
应付债券261,9901.93%257,030263,169245,4520
其他非流动负债42,577-1.37%43,1688,57924,90361,651
479,0825.02%456,164434,966370,684117,971

总权益
    实收股本405,0690.00%405,069401,317400,860400,860
    储备项目488,553-2.10%499,011467,689448,134564,031
股东权益893,622-1.16%904,080869,005848,994964,891
非控股权益5,80061.11%3,6001,237(266)(190)